Marazziti Donatella, Mungai Francesco, Vivarelli Laura, Presta Silvio, Dell'Osso Bernardo
Dipartimento di Psichiatria, Neurobiologia, Farmacologia e Biotecnologie, University of Pisa, Italy.
Clin Pract Epidemiol Ment Health. 2006 Nov 6;2:31. doi: 10.1186/1745-0179-2-31.
Pain is one of the most difficult medical problems to diagnose and treat and can be a common symptom of several psychiatric disorders. Pain-related issues are heterogeneous and often underestimated or misinterpreted, with the result that psychiatric interventions, which might have been beneficial from the outset, are often delayed or requested only as a last measure. Several problems arise from the definition, classification and assessment of pain, when documented according to the different scales which are commonly used, since these attempt to cover a multitude of analytical requirements, without really succeeding. An area of constant debate regards the connection between pain and various psychiatric disorders, and the difficulty in the classification of pain disorders within the currently existing framework. The pharmacological treatment of pain is complex and implies a variety of different compounds, from opioids to psychotropic medications like antidepressants and anticonvulsivants. This paper explores the mutual and reciprocal influence between pain and psychiatric disorders reviewing the latest developments in the definition, assessment and treatment of pain, with special emphasis on the impact of pain on psychiatric disorders (and vice versa), and on the use of psychotropic drugs in the treatment of pain syndromes.
疼痛是最难诊断和治疗的医学问题之一,并且可能是多种精神障碍的常见症状。与疼痛相关的问题具有异质性,常常被低估或误解,结果是那些从一开始可能就有益的精神科干预措施常常被延迟,或者仅在最后才被要求采用。当根据常用的不同量表记录疼痛时,疼痛的定义、分类和评估会出现几个问题,因为这些量表试图涵盖众多分析要求,但并未真正成功。一个持续争论的领域涉及疼痛与各种精神障碍之间的联系,以及在现有框架内对疼痛障碍进行分类的困难。疼痛的药物治疗很复杂,涉及多种不同的化合物,从阿片类药物到抗抑郁药和抗惊厥药等精神药物。本文探讨了疼痛与精神障碍之间的相互影响,回顾了疼痛定义、评估和治疗方面的最新进展,特别强调了疼痛对精神障碍的影响(反之亦然),以及精神药物在疼痛综合征治疗中的应用。